IgG4‐related brain pseudotumor mimicking CNS lymphoma. A case report

Here, we report a case of IgG4‐related brain pseudotumor (IgG4‐BP) in a 39‐year‐old woman, mimicking central nervous system (CNS) lymphoma. She presented with headache, fever, and fatigue. Her medical history was notable for appearance of a tumefactive brain lesion seven years before. Brain biopsy performed at the age of 32 revealed nonspecific inflammatory changes, and her condition improved with oral low‐dose steroid therapy. Magnetic resonance imaging performed at the age of 39 identified a hyperintensity lesion with edema located at the medial temporal lobe region adjacent to the inferior horn of the left lateral ventricle on fluid‐attenuated inversion recovery images, which showed gadolinium‐contrast enhancement on T1‐weighted images and a slightly hyperintensity signal on diffusion‐weighted images. Methionine‐positron emission tomography (PET) depicted a high methionine uptake in the lesion. Additionally, soluble levels of interleukin (IL)‐2 receptor (sIL‐2R) and IL‐10 were increased in cerebrospinal fluid (CSF). Based on these findings, we suspected CNS lymphoma and performed partial resection of the brain lesion. Pathological examination revealed prominent lymphocytic infiltration associated with plasma cell infiltration. Most of the plasma cells were immunoreactive for IgG4. Storiform fibrosis and partially obliterative phlebitis were concomitantly observed. Thus, the patient was diagnosed as having IgG4‐BP. To the best of our knowledge, this is the first case report of IgG4‐BP with detailed findings obtained by CSF testing, methionine‐PET, and pathological examination. Because IgG4‐related diseases can present as a pseudotumor that mimics CNS lymphoma, it is essential to carefully differentiate IgG4‐BP from CNS lymphoma.

[1]  Cheng-Han Wu,et al.  The Cellular and Molecular Bases of Allergy, Inflammation and Tissue Fibrosis in Patients with IgG4-related Disease , 2020, International journal of molecular sciences.

[2]  Yan Wang,et al.  Inflammatory Demyelinating Pseudotumor With Liver Dysfunction: IgG4 Related Disease With Primary Biliary Cholangitis. , 2020, The American journal of the medical sciences.

[3]  Cong Ye,et al.  Biomarkers in IgG4-related disease: A systematic review. , 2020, Seminars in arthritis and rheumatism.

[4]  Amita Sharma,et al.  The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease , 2019, Annals of the rheumatic diseases.

[5]  Y. Otsuki,et al.  Intracranial multiple pseudotumor due to immunoglobulin G4-related disease without other lesion: case report and literature review. , 2019, World neurosurgery.

[6]  D. Fontaine,et al.  Immunoglobulin G4-related hypertrophic pachymeningitis , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[7]  S. Ichimiya,et al.  IL-10+ T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease. , 2019, Immunology letters.

[8]  D. Munoz,et al.  IgG4-related intracranial disease , 2018, The neuroradiology journal.

[9]  L. Niu,et al.  IgG4-related inflammatory pseudotumor of the brain parenchyma: a case report and literature review , 2018, Acta Neurologica Belgica.

[10]  J. Xiong,et al.  Clivus Inflammatory Pseudotumor Associated with Immunoglobulin G4-Related Disease. , 2018, World neurosurgery.

[11]  K. Kitagawa,et al.  CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma , 2018, Multiple sclerosis.

[12]  W. Dik,et al.  Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease , 2018, Mediators of inflammation.

[13]  K. Kubo,et al.  Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease , 2018, Modern rheumatology.

[14]  S. Kaech,et al.  Interleukin-10 from CD4+ follicular regulatory T cells promotes the germinal center response , 2017, Science Immunology.

[15]  J. Stone,et al.  IgG4-related disease , 2017, Current opinion in rheumatology.

[16]  D. D'cruz,et al.  Neurologic Manifestations of Systemic Disease (n Scolding and C Rice, Section Editors) Neurological Manifestations of Igg4-related Disease , 2022 .

[17]  A. Bal,et al.  IgG4-related inflammatory pseudotumor: A systematic review of histopathological features of reported cases , 2017, Modern rheumatology.

[18]  A. Vossough,et al.  Neuroimaging in Central Nervous System Lymphoma. , 2016, Hematology/oncology clinics of North America.

[19]  L. Xia,et al.  IgG4-related spinal pachymeningitis , 2016, Clinical Rheumatology.

[20]  G. Leung,et al.  IgG4-Related Hypertrophic Pachymeningitis at the Falx Cerebrii with Brain Parenchymal Invasion: A Case Report. , 2015, World neurosurgery.

[21]  K. Togashi,et al.  Total lesion glycolysis as an IgG4-related disease activity marker , 2015, Modern rheumatology.

[22]  N. Mikuni,et al.  IgG4-related disease initially presented as an orbital mass lesion mimicking optic nerve sheath meningioma , 2015, Brain Tumor Pathology.

[23]  N. Saito,et al.  Intracranial Inflammatory Pseudotumors Associated with Immunoglobulin G4-Related Disease Mimicking Multiple Meningiomas: A Case Report and Review of the Literature. , 2015, World neurosurgery.

[24]  Nir Giladi,et al.  Central nervous system manifestation of IgG4-related disease. , 2014, JAMA neurology.

[25]  Fengchun Zhang,et al.  B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren’s syndrome: the similarities and differences , 2014, Arthritis Research & Therapy.

[26]  Kazunari Yoshida,et al.  Immunoglobulin G4-related intracranial inflammatory pseudotumours along both the oculomotor nerves , 2013, BMJ Case Reports.

[27]  S. Galetta,et al.  IgG4-related inflammatory pseudotumor of the central nervous system responsive to mycophenolate mofetil , 2012, Journal of the Neurological Sciences.

[28]  Jong-Hee Chang,et al.  Immunoglobulin G4-related hypertrophic pachymeningitis involving cerebral parenchyma. , 2011, Journal of neurosurgery.

[29]  D. Vignali,et al.  Regulatory T cells and inhibitory cytokines in autoimmunity. , 2009, Current opinion in immunology.

[30]  W. Poon,et al.  Inflammatory pseudotumors of the central nervous system. , 2009, Human pathology.

[31]  Kam-cheong Lee,et al.  Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. , 2007, Human pathology.

[32]  Yasunori Sato,et al.  Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease , 2007, Modern Pathology.

[33]  J. Chan Inflammatory Pseudotumor: A Family of Lesions of Diverse Nature and Etiologies , 1996 .

[34]  L A Rubin,et al.  The soluble interleukin-2 receptor: biology, function, and clinical application. , 1990, Annals of internal medicine.